Our media

12 February 2024

Join Stuart Farrow, our VP of Bioscience, for an exclusive exploration into the dynamic realm of academic drug discovery and learn why target validation is crucial for academic drug discovery, and how to select the right target.

June 2023

Join Nikhil Gupta, Principal Scientist at Functional Genomics Centre (FGC), to find out how the FGC is leading the development and improvement of genetic screening tools, with the goal of accelerating the discovery of new cancer medicines.

April 2023

Join Steve Wedge, our Chief Scientific Officer and Mike Waring, our Head of Academic Medicinal Chemistry for this podcast with Drug Discovery World to find out how our Newcastle Drug Discovery site combines the strength of our enhanced drug discovery with that of our academic network. 

January 2023

Join Julie Little, Associate Director of our Strategic Alliances team, and Steve Wedge, Chief Scientific Officer of our Therapeutic Innovation arm to learn how we are leveraging alliances to bridge the translational gap between basic research and drug developments in the BTD Consulting Alliance Matters podcast.

Learn how our unique position helps us catalyse innovations in oncology, as well as the importance of de-risking drug discovery, and how you can work with us.

26-27 October 2022

Hear about "Extensive Sequence and Structural Evolution of Inhibitory Antibodies to Arginase2 Enabled by an Unbiased Approach to Affinity Maturation" from Stuart Haynes, Deputy Laboratory Head at the Antibody Alliance Laboratory. The talk was given as part of Technology Networks' "Advances in Drug Discovery and Development" symposium.

5 July 2022

Hear in our webinar how leading scientists at the Antibody Alliance Laboratory helped discover breakthrough therapies for cancer.

29-30 June 2022

Hear from Sofia Lourenco, our Principal Scientist, how our specialised, thematic alliances enable a deeper deconvolution across the multiple compartments present in the tumour microenvironment. The talk was given as part of Technology Networks' "The Landscape of Cancer Research" symposium.